Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsSupportive Therapy, ToxicityProtocol groupComplicationsNeuro-OncologyradiotherapyDiseaseRadionecrosisSubgroupcerebralICD10T66MeSHRadiation InjuriesSequenceAntineoplastic therapySubstanceSubstanceSubstanceSubstanceNo. Substances RadiotherapySupportive therapySubstanceBalanced Crystalloid SolutionBevacizumabSubstanceBalanced Crystalloid SolutionBevacizumabSubstanceBalanced Crystalloid SolutionBevacizumabSubstanceBalanced Crystalloid SolutionBevacizumabNo. Substances2Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationSecond lineTherapy phaseTherapy intentioncurative or palliativeRisksEmetogenicity (MASCC/ESMO)PneumoniaThromboembolic Event only studiesPublicationAuthorLevin VADiseaseZerebrale Radionekrose, nach Therapie mit DexamethasonOriginDepartment of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TexasProtocols in Revision 1 protocol foundBevacizumab 7.5, Radionecrosis (PID2138 V1.0)
